Author | David Hutton


US FDA approves to Ml6710i laser for use with Visudyne

According to a news release from Bausch + Lomb and biomedical laser company Modulight, the FDA has approved the ML6710i photodynamic laser for equivalent use with Visudyne.

Apellis submits marketing authorisation application to the European Medicines Agency for pegcetacoplan for geographic atrophy

Pegcetacoplan is the only GA treatment to demonstrate increased effects over 24 months across a broad patient population.

Re-Vana Therapeutics raises $11.9 million to advance ophthalmic technology platforms

The funding will give a boost to the development of the company's novel photo-crosslinked EyeLief, EyeLief-SD, and OcuLie biodegradable drug-delivery technologies.